Synergetics USA (NASDAQ: SURG) reported Q3 EPS of $0.05, $0.01 better than the analyst estimate of $0.04. Revenue for the quarter came in at $19.4 million versus the consensus estimate of $19.16 million.

EBITDA increased 36.1% to $2.6 million, compared to $1.9 million last year.

For earnings history and earnings-related data on Synergetics USA (SURG) click here.